Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.32M Sell
24,854
-3,434
-12% -$1.09M 2.22% 23
2026
Q1
$7.09M Buy
28,288
+13,683
+94% +$3.04M 3.4% 11
2025
Q4
$2.37M Buy
+14,605
New +$2.54M 0.84% 31
2025
Q1
Sell
-8,971
Closed -$1.02M 78
2024
Q4
$1.02M Buy
+8,971
New +$1.07M 0.41% 44
2024
Q3
Sell
-17,875
Closed -$1.55M 85
2024
Q2
$1.55M Sell
17,875
-2,825
-14% -$257K 0.64% 40
2024
Q1
$1.69M Buy
20,700
+400
+2% +$25.1K 0.75% 38
2023
Q4
$975K Buy
+20,300
New +$864K 0.54% 43

Other funds holding VRT

Geneva Partners's VRT Position: Q2 2026 in Review

Geneva Partners reduced its Vertiv (VRT) stake by 12% in Q2 2026, selling an estimated $1.09M and leaving 24,854 shares worth $8.32M. The position accounts for 2.22% of the portfolio, ranked #23.

Geneva Partners first reported a position in VRT in Q4 2023 and has held it in 7 quarters since. 2,055 funds tracked by Wall St. Rank hold VRT as of Q2 2026.

  • Geneva Partners held 24,854 shares of Vertiv worth $8.32M as of Q2 2026.
  • Geneva Partners sold 3,434 Vertiv shares in Q2 2026, an estimated $1.09M.
  • Vertiv made up 2.22% of Geneva Partners's portfolio in Q2 2026, its #23 holding.
  • Geneva Partners first reported a position in Vertiv in Q4 2023 and has held it in 7 quarters since.
  • 2,055 funds tracked by Wall St. Rank held Vertiv as of Q2 2026.

Based on Geneva Partners's 13F filing for Q2 2026, filed 10 Aug 2026.